PDS Biotechnology PDS Biotechnology is a biopharmaceutical company focused on the development and commercialization of therapies based on the versamune platform. | |||
Founding Date | Founding Date 2005 | Founding Date 1997 | Founding Date 2003 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Princeton, US HQ Florham Park, US | Locations Planegg, DE HQ | Locations Modi'in-Maccabim-Re'ut, IL HQ |
Employees | Employees 317% increase | Employees 13 | Employees 2414% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 74 m | Valuation ($) 38.5 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €336k (FY, 2024) | Revenue (est.) $1.2m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods €84k (FY, 2024) | Cost of goods $230k (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit €261k (FY, 2024) | Gross profit $950k (FY, 2025) |
Net income | Net income ($34.5m) (FY, 2025) | Net income (€8.3m) (FY, 2024) | Net income ($2m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 2m | Total funding raised N/A | Total funding raised $ 100.9m |

4SC is a biopharmaceutical company developing small-molecule drugs for the treatment of cancer.
View company
BioLineRx is a biopharmaceutical company focused on oncology.
View company